Tirzepatide Tirzepatide is a newer medication that works as a dual GIP/GLP-1 receptor agonist, targeting two hormones involved in appetite and blood sugar regulation
J Clin Endocrinol Metab 2009
No, you should not self-adjust your GLP-1 medication dose
The plate was incubated at room temperature for 510 min, before luminescence was measured using a Victor 3 1420 Multilabel Counter (Wallac 1420 Workstation, version 3.00 revision 5
Despite this, many patients persevere because of the undeniable benefits these medications offer
Resources: Pillar 5: SGLT-2 inhibitors SGLT-2 inhibitors lower glucose by increasing urinary glucose excretion, reducing glucose toxicity, and often reducing insulin requirements, without directly increasing insulin